Anaferon baby drops, 25 ml

Treatment of acute respiratory infections of the upper respiratory tract in children aged 1 month to 3 years inclusive.

The drug is taken orally, outside the meal. On the first day of treatment, the first 5 doses of the drug should be carried out between feedings or 15 minutes before feeding the child or taking fluids. 10 drops are prescribed per dose (the drops are dosed into a spoon). On the first day of treatment: the first 2 hours - 10 drops each. every 30 minutes, then, in the remaining time, 3 more times at regular intervals. From 2 to 5 days - 10 drops 3 times / day.

Drops for oral administration in the form of a colorless or almost colorless transparent liquid.

1 ml

antibodies to human gamma interferon affinity purified 0.006 g *

* are introduced in the form of a mixture of three active aqueous dilutions of the substance, diluted 10012, 10030, 10050 times, respectively.

Excipients: maltitol - 0.06 g, glycerol - 0.03 g, potassium sorbate - 0.00165 g, anhydrous citric acid - 0.0002 g, purified water - up to 1 ml.

• Children's age up to 1 month;

• increased individual sensitivity to the components of the drug.

pharmachologic effect

The drug has an immunomodulatory and antiviral effect. In the course of preclinical and clinical studies, the effectiveness of the drug has been proven against influenza viruses, parainfluenza, herpes simplex viruses of types 1 and 2 (labial herpes, genital herpes), other herpes viruses (chickenpox, infectious mononucleosis), enteroviruses, tick-borne encephalitis virus, rotavirus , coronavirus, calicivirus, adenovirus, respiratory syncytial (PC virus). The drug reduces the concentration of the virus in the affected tissues, affects the system of endogenous interferons and associated cytokines, induces the formation of endogenous 'early' interferons (IFN? /?) And interferon gamma (IFN?). Stimulates the humoral and cellular immune response. Increases the production of antibodies (including secretory IgA), activates the functions of T-effectors, T-helpers (Tx),normalizes their ratio. Increases the functional reserve of Th and other cells involved in the immune response. It is an inducer of a mixed Tx1 and Th2 immune response: it increases the production of cytokines Tx1 (IFN?, IL-2) and Th2 (IL-4, 10), restores (modulates) the balance of Th1 / Th2. Increases the functional activity of phagocytes and natural killer cells (NK cells). Possesses antimutagenic properties.

Side effect

When used according to the indicated indications and in the indicated dosages, no side effects have been identified. Possible reactions of increased individual sensitivity to the components of the drug.

Application during pregnancy and lactation

The safety of using Anaferon for children during pregnancy and lactation has not been studied.

Application in children

It is contraindicated for use in children under 1 month of age.

Overdose

Overdose cases have not been identified so far.

Drug interactions

No cases of incompatibility with other drugs have been registered to date.